Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-Announces-European-Commission-Approves-KEYTRUDA-pembrolizumab-Plus-Chemotherapy-as-Neoadju-40540114/?utm_source=whatsapp&utm_medium=social&utm_campaign=share